Drugs
BALTIMORE, MD: BALTIMORE, MD -- (Marketwire) -- 05/21/12 -- , a biopharmaceutical company focused on the discovery, development and commercialization of prescription pharmaceuticals whose primary activity is in th ...
WEST PALM BEACH, FL: Phase I Study Is First-in-Human Trial of an Oral VEGFR Tyrosine Kinase Inhibitor (TKI) in Patients With Advanced Solid Tumors ...
NEW YORK, NY: NEW YORK, NY -- (Marketwire) -- 05/15/12 -- (OTCBB: KDUS) announced today financial results for the first quarter ended March 31, 2012.Revenues for the first quarter of 2012 were $0, compared to $0 ...
WEST LAFAYETTE, IN: WEST LAFAYETTE, IN -- (Marketwire) -- 05/11/12 -- (NASDAQ: BASI) (BASi) today announced financial results for the second quarter and first half of fiscal 2012."BASi's second quarter result ...
LOS ANGELES, CALIFORNIA: LOS ANGELES, CALIFORNIA -- (Marketwire) -- 05/07/12 -- Marketwire issued a news release earlier today on behalf of Arena Pharmaceuticals, Inc. (NASDAQ;ARNA) in error entitled, "Arena Pharmaceut ...
LOS ANGELES, CALIFORNIA: LOS ANGELES, CALIFORNIA -- (Marketwire) -- 05/07/12 -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) is awaiting its opportunity to readdress the U.S. Federal Food and Drug Administration's Adviso ...
SAN DIEGO, CA: SAN DIEGO, CA -- (Marketwire) -- 05/07/12 -- Ardea Biosciences, Inc. (NASDAQ: RDEA), a biotechnology company focused on the development of small-molecule therapeutics for the treatment of serious di ...
PRINCETON, NJ: Greater Philadelphia Alliance for Capital and Technologies (PACT) Awards Celebrate Innovation and Leadership in Life Sciences ...
AURORA, ON: AURORA, ON -- (Marketwire) -- 05/03/12 -- Helix BioPharma Corp. (TSX: HBP) (NYSE Amex: HBP) (FRANKFURT: HBP) announced today that, in compliance with applicable corporate law, it is seeking an Order ...
CONSHOHOCKEN, PA: CONSHOHOCKEN, PA -- (Marketwire) -- 05/03/12 -- NuPathe Inc. (NASDAQ: PATH), a biopharmaceutical company focused on the development and commercialization of branded therapeutics for diseases of the ...
WOODBRIDGE, ONTARIO: WOODBRIDGE, ONTARIO -- (Marketwire) -- 04/30/12 -- Pivotal Therapeutics Inc. (OTCQX: PVTTF)(CNSX: PVO), a specialty pharmaceutical company with a focus on the treatment of cardiovascular disease, to ...
FOSTER CITY, CA: FOSTER CITY, CA -- (Marketwire) -- 04/30/12 -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today filed a prospectus supplement to a previously effective Form S-3 registration statement, pursuant to ...
LEUVEN, BELGIUM: LEUVEN, BELGIUM -- (Marketwire) -- 04/24/12 -- TiGenix (EURONEXT BRUSSELS: TIG) announced today that further to the cGMP inspection by the Dutch authorities it has obtained the manufacturing authoriz ...
SAN DIEGO,CA: SAN DIEGO,CA -- (Marketwire) -- 04/23/12 -- AstraZeneca and Ardea Biosciences, Inc. (NASDAQ: RDEA) today announced that they have entered into a definitive merger agreement, pursuant to which AstraZ ...
SOUTH SAN FRANCISCO, CA: Additional Preclinical Trial Data to Be Presented at the 2012 Experimental Biology Conference ...
BRIDGEWATER, NJ: BRIDGEWATER, NJ -- (Marketwire) -- 04/18/12 -- (the "Company") today announced that as of 5:00 p.m., New York City time, on April 17, 2012 (the "Consent Deadline"), it had recei ...
BEDFORD, MA: New Applications Improve the Efficiency of Microbial Quality Control Processes While Significantly Reducing the Time-to-Result ...
MOSCOW: MOSCOW -- (Marketwire) -- 04/12/12 -- Cromos™ Pharma has announced today an addition of a new service -- registration of medicinal products in the Russian Federation."Russia's process of ...
BALTIMORE, MD: BALTIMORE, MD -- (Marketwire) -- 04/11/12 -- , a biopharmaceutical company focused on the discovery, development and commercialization of prescription pharmaceuticals whose primary activity is in th ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwire) -- 04/11/12 -- Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced it has earned a $20 million milestone payment from Merck KGaA, Darmstadt, German ...
